199 related articles for article (PubMed ID: 23939904)
21. [Combination of lamivudine with thymosin alpha1 in treatment of duck hepatitis B].
Chen XM; Liu ZM; Du XF; Yang ZG; Chen XM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):121-5. PubMed ID: 15812884
[TBL] [Abstract][Full Text] [Related]
22. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.
Zhou Z; Zhang Y; Ding XR; Chen SH; Yang J; Wang XJ; Jia GL; Chen HS; Bo XC; Wang SQ
Antiviral Res; 2007 Apr; 74(1):59-64. PubMed ID: 17298850
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
[TBL] [Abstract][Full Text] [Related]
24. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver.
Wei PH; Wu SZ; Mu XM; Xu B; Su QJ; Wei JL; Yang Y; Qin B; Xie ZC
J Ethnopharmacol; 2015 Feb; 160():1-5. PubMed ID: 25446633
[TBL] [Abstract][Full Text] [Related]
25. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
[TBL] [Abstract][Full Text] [Related]
27. Anti-hepatitis B virus activity of α-DDB-FNCG, a novel nucleoside-biphenyldicarboxylate compound in vitro and in vivo.
Yang Q; Zhao X; Yu W; He W; Fang X; Zang L; Wan N; Wang Q; Zheng L; Chang J
J Pharmacol Sci; 2014; 126(3):208-15. PubMed ID: 25409748
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Chen Y; Guo S; Qi Z; Huang A
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):209-11. PubMed ID: 11602049
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study on effect of Shenling Yigan Granule in antagonizing duck hepatitis B virus].
Zhang HQ; Ge H; Li X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Mar; 27(3):244-6. PubMed ID: 17432688
[TBL] [Abstract][Full Text] [Related]
31. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
32. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
Schorr O; Borel C; Trepo C; Zoulim F; Hantz O
J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of duck hepatitis B virus infection by lysosomotropic agents.
Offensperger WB; Offensperger S; Walter E; Blum HE; Gerok W
Virology; 1991 Jul; 183(1):415-8. PubMed ID: 2053292
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
Guillot C; Martel N; Berby F; Bordes I; Hantz O; Blanchet M; Sureau C; Vaillant A; Chemin I
PLoS One; 2017; 12(6):e0179697. PubMed ID: 28636622
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
Munshi A; Mehrotra R; Panda SK
Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
[TBL] [Abstract][Full Text] [Related]
36. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N; Civitico G; Wang YY; Guo KJ; Birch C; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):82-9. PubMed ID: 2388048
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
Han YQ; Huang ZM; Yang XB; Liu HZ; Wu GX
J Ethnopharmacol; 2008 Jun; 118(1):148-53. PubMed ID: 18495393
[TBL] [Abstract][Full Text] [Related]
38. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
Beilstein F; Blanchet M; Vaillant A; Sureau C
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
[TBL] [Abstract][Full Text] [Related]
39. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
40. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]